tiprankstipranks
Zoetis (ZTS)
NYSE:ZTS
Holding ZTS?
Track your performance easily

Zoetis (ZTS) Income Statement

3,290 Followers

Zoetis Income Statement

Last quarter (Q4 2023), Zoetis's total revenue was $2.21B, an increase of 8.48% from the same quarter last year. In Q4, Zoetis's net income was $525.00M. See Zoetis’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.54B$ 8.54B$ 8.08B$ 7.78B$ 6.67B$ 6.26B
Cost of Revenue
$ 2.56B$ 2.56B$ 2.45B$ 2.30B$ 2.06B$ 1.99B
Gross Profit
$ 5.98B$ 5.98B$ 5.63B$ 5.47B$ 4.62B$ 4.27B
Operating Expense
$ 2.77B$ 2.77B$ 2.70B$ 2.67B$ 2.35B$ 2.25B
Operating Income
$ 3.22B$ 3.22B$ 2.93B$ 2.80B$ 2.27B$ 2.02B
Net Non Operating Interest Income Expense
$ -239.00M$ -239.00M$ -261.00M$ -272.00M$ -219.00M$ -186.00M
Other Income Expense
$ -159.00M$ -159.00M-$ -30.00M$ -54.00M$ -31.00M
Pretax Income
$ 2.94B$ 2.94B$ 2.66B$ 2.49B$ 2.00B$ 1.80B
Tax Provision
$ 596.00M$ 596.00M$ 545.00M$ 454.00M$ 360.00M$ 301.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 2.40B$ 2.34B$ 2.11B$ 2.04B$ 1.64B$ 1.50B
Basic EPS
$ 5.07$ 5.08$ 4.51$ 4.29$ 3.44$ 3.14
Diluted EPS
$ 5.07$ 5.07$ 4.49$ 4.27$ 3.42$ 3.11
Basic Average Shares
$ 1.84B$ 461.17M$ 468.89M$ 474.35M$ 475.50M$ 478.13M
Diluted Average Shares
$ 1.85B$ 462.27M$ 470.38M$ 476.72M$ 478.57M$ 481.79M
Dividend Per Share
$ 1.14-$ 1.35$ 1.08$ 0.80$ 0.66
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ 3.85$ 3.64
Rent Expense Supplemental
------
Total Expenses
$ 5.33B$ 5.33B$ 5.15B$ 4.97B$ 4.41B$ 4.24B
Net Income From Continuing And Discontinued Operation
$ 2.34B$ 2.34B$ 2.11B$ 2.04B$ 1.64B$ 1.50B
Normalized Income
$ 1.86B$ 2.37B--$ 1.69B$ 1.54B
Interest Expense
----$ 231.00M$ 223.00M
EBIT
$ 3.17B$ 3.17B$ 2.88B$ 2.71B$ 2.23B$ 2.02B
EBITDA
$ 3.67B$ 3.67B$ 3.34B$ 3.16B$ 2.67B$ 2.44B
Currency in USD

Zoetis Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis